Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 22.92

From 52W high−66.50%

Volume19.56M

Market capCNY 21.49B

P/E (TTM)−60.0x

P/S (TTM)24.3x

Div yield—

Key dataSep 18, 2026

Open

CNY 22.92

From 52W high

−66.50%

Volume

19.56M

Market cap

CNY 21.49B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−83.0x

P/E (TTM)

−60.0x

RSI (14)

42.2

MomentumView details →

1D Return

−4.69%

YTD Return

−62.87%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

−60.0x

EV/EBITDA

−83.0x

EV/Sales

26.7x

P/S (TTM)

24.3x

P/B (TTM)

17.8x

ProfitabilityView details →

Gross Margin

15.55%

Net Margin

−40.78%

EBITDA Margin

−32.19%

ROE (TTM)

−29.40%

ROA (TTM)

−8.02%

Asset Turnover

0.20x

GrowthView details →

Revenue YoY

−12.33%

EPS YoY

—

FCF YoY

+13.77%

Revenue CAGR 3Y

−27.91%

EPS CAGR 3Y

−44.44%

EBITDA YoY

—

MomentumView details →

1D Return

−4.69%

YTD Return

−62.87%

1Y Return

−48.62%

RSI (14)

42.2

vs 50D SMA

−9.51%

vs 200D SMA

−43.33%

Capital & dividendView details →

Debt/Equity

1.93x

Current Ratio

0.74x

Quick Ratio

0.25x

Div Yield

—

Div Rate

—

Div Growth 1Y

−80.77%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

872.53M

Net Income (TTM)

−355.81M

Op. CF (TTM)

−27.10M

Latest newsMore news →

Changshan Pharmaceuticals announced on September 16 that it received investors' online questions in a research session, with Chairman Gao Xiaodong, Board Secretary Liu Zhongying, and CFO Yue Xiaohua receiving them.5d ago

Changshan Pharmaceuticals announced that its heparin sodium injection received a drug registration certificate from Moldova's drug regulatory authority.6d ago

Similar companies

吉林敖东000623.SZ 航天发展000547.SZ 众生药业002317.SZ 宏达电子300726.SZ 华测导航300627.SZ 乐普医疗300003.SZ Find similar companies →

Latest newsMore news →

Changshan Pharmaceuticals announced on September 16 that it received investors' online questions in a research session, with Chairman Gao Xiaodong, Board Secretary Liu Zhongying, and CFO Yue Xiaohua receiving them.5d ago Changshan Pharmaceuticals announced that its heparin sodium injection received a drug registration certificate from Moldova's drug regulatory authority.6d ago